Symmetry Partners’s Zimmer Biomet ZBH Stock Holding History

Symmetry Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,565	Closed	-$278K	–	515
2024 Q2	$278K	Hold	2,565	–	–	0.01%	425
2024 Q1	$339K	Hold	2,565	–	–	0.03%	387
2023 Q4	$312K	Hold	2,565	–	–	0.02%	389
2023 Q3	$288K	Sell	2,565 -405	-14%	-$51.4K	0.02%	436
2023 Q2	$432K	Hold	2,970	–	–	0.02%	379
2023 Q1	$384K	Hold	2,970	–	–	0.02%	398
2022 Q4	$379K	Hold	2,970	–	–	0.02%	404
2022 Q3	$311K	Hold	2,970	–	–	0.02%	436
2022 Q2	$312K	Hold	2,970	–	–	0.02%	455
2022 Q1	$380K	Sell	2,970 -89	-3%	-$10.7K	0.02%	450
2021 Q4	$377K	Hold	3,059	–	–	0.02%	473
2021 Q3	$434K	Sell	3,059 -190	-6%	-$27.9K	0.03%	463
2021 Q2	$507K	Sell	3,249 -650	-17%	-$105K	0.03%	421
2021 Q1	$606K	Sell	3,899 -411	-10%	-$63.7K	0.04%	334
2020 Q4	$645K	Buy	4,310 +21	+0.5%	+$2.97K	0.05%	291
2020 Q3	$567K	Buy	+4,289	New	+$560K	0.05%	287
2019 Q2	–	Sell	-1,482	Closed	-$184K	–	430
2019 Q1	$184K	Hold	1,482	–	–	0.03%	320
2018 Q4	$149K	Buy	+1,482	New	+$167K	0.04%	297

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Symmetry Partners's ZBH Position: Q3 2024 in Review

Symmetry Partners sold out of Zimmer Biomet (ZBH) in Q3 2024, closing a stake of 2,565 shares — an estimated $278K sold.

Symmetry Partners first reported a position in ZBH in Q4 2018 and held it in 18 quarters. The position peaked at $645K in Q4 2020. 981 funds tracked by Wall St. Rank hold ZBH as of Q3 2024.

Symmetry Partners reported no remaining Zimmer Biomet position as of Q3 2024 after selling out during the quarter.
Symmetry Partners sold 2,565 Zimmer Biomet shares in Q3 2024, an estimated $278K.
Symmetry Partners first reported a position in Zimmer Biomet in Q4 2018 and held it in 18 quarters.
Symmetry Partners's Zimmer Biomet position peaked at $645K in Q4 2020.
981 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2024.

Based on Symmetry Partners's 13F filing for Q3 2024, filed 29 Oct 2024.